Agendia to participate in groundbreaking clinical trial for breast cancer

[News]

Agendia, a world leader in molecular cancer diagnostics, announced today it will participate in the highly anticipated I-SPY 2 TRIAL for breast cancer, set to launch at the first of nearly twenty research sites.

More... (http://www.news-medical.net/news/20100318/Agendia-to-participate-in-groundbreaking-clinical-trial-for-breast-cancer.aspx)